Ototoxicity of Netilmicin

References

• Anniko M. Effects of gentamicin on the development of the embryonic inner ear in organ culture. Aminoglycoside Ototoxicity, S. A. Lerner, G. J. Matz, J. E. Hawkins, Jr. Little, Brown & Co. 1980, 1981
   Google Scholar
• Belfrage S., Banck G., Nordström L. Treatment with gentamicin. Application and therapeutic effect. Acta Pathol Microbiol Scand (B), Suppl. 1973; 241: 62
   Google Scholar
• Black R. E., Lau W. K., Weinstein R. J., Young L. S., Hewitt W. L. Ototoxicity of amikacin. Antimicrob Agents Chemother 1976; 9: 956
   PubMed Web of Science ®Google Scholar
• Brummet R. E., Fox K. E., Bendrick T. W., Himes D. Otoxicity of tobramycin, gentamicin, amikacin and sisomicin in the guinea pig. J Antimicrobial Chemother 1978; 4, Suppl. A
   Web of Science ®Google Scholar
• Brummet R. E., Traynor J., Himes D. Cochlear damage resulting from kanamycin and furosemide. Acta Otolaryngol (Stockh) 1975; 80: 86
   PubMed Web of Science ®Google Scholar
• Dahlager J. I. The effect of netilmicin and other aminoglycosides on renal function. Scand J Infect Dis, Suppl. 1980; 23: 96
   PubMedGoogle Scholar
• David D. S., Hitzig P. Diuretics and ototoxicity. New EnglJ Med 1971; 284: 1328
   PubMed Web of Science ®Google Scholar
• Denneberg T., Haeger K., Juhlin I. Netilmicin therapy of serious renal and urinary tract infections in patients with normal and impaired renal function. Scand J Infect Dis 1980; 135, Suppl. 23
   Google Scholar
• Erlandsson B., Håkanson H., Ivarsson A., Nilsson P. Comparison of the hearing threshold measured by manual pure-tone and by self-recording (Békésy) audiometry. Andiology 1979; 18: 414
   PubMedGoogle Scholar
• Federspil P. Über die klinische Ototoxicität des Gentamicins und ihre Reversibilität. Arch Klin Exp Ohren Nasen Kehlkopfheilkd 1970; 196: 237
   PubMedGoogle Scholar
• Federspil P. Ototoxicity and nephrotoxicity of netilmicin. Infection 1976; 4: 211
   PubMed Web of Science ®Google Scholar
• Federspil P., Schatzle W. Experimental evaluation of the ototoxicity of tobramycin, sisomicin, amikacin and netilmicin. Inner Ear Biology, M. Portmann, J. M. Aran. Inserm, Paris 1977; 319–326, WV 250, 158
   Google Scholar
• Fu K. P., Neu H. C. In vitro study of netilmicin compared with other aminoglycosides. Antimicrob Agents Chemother 1976; 10: 526
   PubMed Web of Science ®Google Scholar
• Hawkins J. E. Comparative otopathology: Aging, noise and ototoxic drugs. Adv Otorhinolarvngol 1973; 20: 125
   PubMedGoogle Scholar
• Hewitt W. L. Gentamicin: toxicity in perspective. Postgrad Med J 1974; 50: 55, Suppl. 7
   PubMed Web of Science ®Google Scholar
• Jackson G. G., Arcieri G. Ototoxicity of gentamicin in man: A survey and controlled analysis of clinical experience in the United States. J Infect Dis 1971; 124: 130
   PubMed Web of Science ®Google Scholar
• Lerner S. A., Seligsohn R., Matz G. J. Comparative clinical studies of ototoxicity and nephrotoxicity of amikacin and gentamicin. Am J Med 1977; 62: 92
   Web of Science ®Google Scholar
• Luft F. C, Yum M. N., Kleit S. A. Comparative nephrotoxicities of netilmicin and gentamicin in rats. Antimicrob Agents Chemother 1977; 10: 845
   Web of Science ®Google Scholar
• Meyers R. E. Ototoxic effects of gentamicin. Arch Otolaryngol 1976; 92: 160
   Google Scholar
• Miller G. H., Arcieri G., Weinstein M. J., Waitz J. A. Biological activity of netilmicin, a broad-spectrum semisynthetic aminoglycoside antibiotic. Antimicrob Agents Chemother 1976; 10: 827
   PubMed Web of Science ®Google Scholar
• Neu H. C., Bendusch C. L. Ototoxicity of tobramycin: A clinical overview. J Infect Dis 1976; 134: 206
   Web of Science ®Google Scholar
• Nordström L., Banck G., Belfrage S., Juhlin I., Tjernström Ö., Toremalm N. G. Prospective study of the ototoxicity of gentamicin. Acta Pathol Microbiol Scand (B), Suppl. 1973; 241: 58
   Google Scholar
• Nordström L. Personal experience of gentamicin ototoxicity. Round Table Discussion on Gentamicin and Tobramicin The Royal Society of Medicine, International congress and symposium series 4, R. G. Richardson. Academic Press, London 1978; 39, Grune & Stratton, New York
   Google Scholar
• Quick C. A., Hoppe W. Permanent deafness associated with furosemide administration. Ann Otol Rhinol Laryngol 1975; 84: 94
   PubMed Web of Science ®Google Scholar
• Rahal J. J., Jr., Simberkoff M. S., Kagan K., Moldover N. H. Bactericidal efficacy of Sch 20569 and amikacin against gentamicin sensitive and resistant organisms. Antimicrob Agents Chemother 1976; 9: 595
   PubMed Web of Science ®Google Scholar
• Ramsden A., Wilson P., Gibson W. Immediate effects of intravenous tobramycin and gentamicin on human cochlear function. J Laryngol Otol 1980; 94: 521
   PubMed Web of Science ®Google Scholar
• Stupp H., Küpper K., Lagler F., Sous H., Quante M. Inner ear concentrations and ototoxicity of different antibiotics in local and systemic application. Audiology 1973; 12: 350
   PubMedGoogle Scholar
• Thomsen J., Bech P., Szpirt W. Otologic symptoms in chronic renal failure. The possible role of aminoglycoside furosemide interaction. Arch Oto-rhinolaryngol 1976; 214: 71
   PubMedGoogle Scholar
• Tjernström Ö., Banck G., Belfrage S., Juhlin I., Nordström L., Toremalm N. G. The ototoxicity of gentamicin. Acta Pathol Microbiol Scand (B)8I, Suppl. 1973; 241: 73
   Google Scholar
• Watanakunakorn C. Comparative in vitro activity of Sch 20656, netilmicin, gentamicin and tobramycin. Antimicrob Agents Chemother 1976; 10: 382
   PubMed Web of Science ®Google Scholar
• Wersäll J., Björkroth B. An aminoglycoside antibiotic, netilmicin, with low ototoxicity in animal experiments. In Abstracts of the 10th International Congress of Chemotherapy, 1980 1977
   Google Scholar
• Wersall J. The ototoxic potential of netilmicin compared with amikacin. Scand J Infect Dis 1980; 104, Suppl. 23
   Google Scholar